Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$907.32 USD
+4.32 (0.48%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $907.33 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (77 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.56 | 1.35 | 9.99 |
Current Quarter Estimate | 10.09 | 7.43 | 60.00 |
Year Ago Quarter Estimate | 10.09 | 0.12 | 52.54 |
Next Quarter Estimate | 11.07 | 7.81 | 61.00 |
Next Year Estimate | 47.36 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.56 | 13.00 | 17.08 |
Next Year | 4.43 | 7.90 | 8.00 |
Last 5 Years | 15.50 | 1.00 | 8.10 |
Next 5 Years | 9.00 | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 20.56 | -2.18 |
Price/Book (MRQ) | 3.80 | 2.01 |
Price/Cash Flow (MRFY) | 20.80 | 14.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 30.14% | -100.99% |
Return on Equity (TTM) | 17.61% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.